Stockreport

Hims & Hers Stock Jumps as FDA Reconsiders Restrictions on Copycat Weight-Loss Drugs [Yahoo! Finance]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF The change would be a boon for Hims & Hers, which makes copycat weight-loss drugs, and has benefited from the limited availability of some obesity medicines. With Mon [Read more]